Gene · 5281
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Circuits and Biomarkers of the Central Nervous System Relating to Astronaut Performance: Summary Report for a NASA-Sponsored Technical Interchange Meeting. | Life (Basel) | 2023 | 37763256 | PubTator, text mining | PubMed |
| Potential Inflammatory Biomarkers for Major Depressive Disorder Related to Suicidal Behaviors: A Systematic Review. | Int J Mol Sci | 2023 | 37762207 | PubTator, text mining | PubMed |
| Endothelial Dysfunction and Pregnant COVID-19 Patients with Thrombophilia: A Narrative Review. | Biomedicines | 2023 | 37760899 | PubTator, text mining | PubMed |
| The Multi-Kinase Inhibitor RepSox Enforces Barrier Function in the Face of Both VEGF and Cytokines. | Biomedicines | 2023 | 37760872 | PubTator, text mining | PubMed |
| Is There a Relationship between Adverse Pregnancy Outcomes and Future Development of Atherosclerosis? | Biomedicines | 2023 | 37760871 | PubTator, text mining | PubMed |
| Predicting late-onset preeclampsia by detecting ELABELA content using an immunochromatographic colloidal gold test strip: Blood ELABELA content predicts the risk of pre-eclampsia. | J Clin Hypertens (Greenwich) | 2023 | 37746730 | PubTator, text mining | PubMed |
| Non-Coding RNAs: Foes or Friends for Targeting Tumor Microenvironment. | Noncoding RNA | 2023 | 37736898 | PubTator, text mining | PubMed |
| Cancer-associated fibroblasts reuse cancer-derived lactate to maintain a fibrotic and immunosuppressive microenvironment in pancreatic cancer. | JCI Insight | 2023 | 37733442 | PubTator, text mining | PubMed |
| Update on immune-based therapy strategies targeting cancer stem cells. | Cancer Med | 2023 | 37698048 | PubTator, text mining | PubMed |
| A Review of 10-Year Survivability of Immunotherapy in the Management of Colon Cancer. | Cureus | 2023 | 37692610 | PubTator, text mining | PubMed |
| Mutational Landscape and Precision Medicine in Hepatocellular Carcinoma. | Cancers (Basel) | 2023 | 37686496 | PubTator, text mining | PubMed |
| Rimonabant and Cannabidiol Rewrite the Interactions between Breast Cancer Cells and Tumor Microenvironment. | Int J Mol Sci | 2023 | 37686233 | PubTator, text mining | PubMed |
| Vascular Endothelial Growth Factor-D (VEGF-D): An Angiogenesis Bypass in Malignant Tumors. | Int J Mol Sci | 2023 | 37686121 | PubTator, text mining | PubMed |
| From Biomarkers to the Molecular Mechanism of Preeclampsia-A Comprehensive Literature Review. | Int J Mol Sci | 2023 | 37686054 | PubTator, text mining | PubMed |
| Cancer Stem Cells in Renal Cell Carcinoma: Origins and Biomarkers. | Int J Mol Sci | 2023 | 37685983 | PubTator, text mining | PubMed |
| Angiogenic and Microvascular Status Alterations after Endovascular Revascularization of Lower Limb Arteries among Patients with Diabetic Foot Syndrome: A Prospective 12-Month Follow-Up Study. | J Clin Med | 2023 | 37685648 | PubTator, text mining | PubMed |
| Pregnancy after kidney transplantation: an observational study on maternal, graft and offspring outcomes in view of current literature. | Front Nephrol | 2023 | 37675349 | PubTator, text mining | PubMed |
| Translational research updates in female health anesthesiology: a narrative review. | Ann Transl Med | 2023 | 37675293 | PubTator, text mining | PubMed |
Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4. | Nat Commun | 2023 | 37673858 | PubTator, text mining | PubMed |
| 27‑Gauge vitrectomy vs. 25‑gauge vitrectomy in the management of proliferative diabetic retinopathy with preoperative intravitreal injection of conbercept. | Exp Ther Med | 2023 | 37664677 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5281/papers?page=8